Insights

Gathering insights about NeuClone…

Similar companies to NeuClone

NeuClone Tech Stack

NeuClone uses 8 technology products and services including RSS, Cloudflare, oEmbed, and more. Explore NeuClone's tech stack below.

RSS
Content Management System
Cloudflare
Content Management System
oEmbed
Dev Tools
Microsoft 365
Email
ProgressBar.js
Javascript Libraries
Modernizr
Javascript Libraries
PHP
Programming Languages
TouchSwipe
Web Tools And Plugins

Media & News

NeuClone Ltd is developing denosumab biosimilar candidate on Jan 1st '18.
Neuclone, an Australian biosimilar developer, also announced that it was in the process of developing a denosumab biosimilar candidate in 2018.
Jun 28, 2022 | www.centerforbiosimilars.com
NeuClone Ltd launched biosimilar candidate of Stelara on Oct 20th '20.
NeuClone Ltd (NeuClone) today announced its biosimilar candidate of Stelara ® (ustekinumab), NeuLara, has successfully met all primary and secondary endpoints in a Phase I clinical trial.
Oct 20, 2020 | www.biospace.com
NeuClone Ltd launched NeuLara on Oct 17th '19.
On October 17, 2019, NeuClone announced that it has launched a Phase I clinical trial of its ustekinumab product, NeuLara.
Oct 31, 2019 | www.jdsupra.com
NeuClone Ltd launches updates regarding respective ustekinumab biosimilars.
Over the last two weeks, NeuClone and Formycon announced updates regarding their respective ustekinumab biosimilars (reference product, Stelara).
Oct 31, 2019 | www.jdsupra.com
NeuClone Ltd is developing ten biosimilars for global registration.
NeuClone and Serum Institute have partnered to develop ten biosimilars for global registration in accordance with the most stringent regulatory standards.
Oct 23, 2018 | www.prnewswire.com

NeuClone's Email Address Formats

NeuClone uses at least 1 format(s):

NeuClone Email Formats	Example	Percentage
F.Last@neuclone.com	J.Doe@neuclone.com	50%
F.Last@neuclone.com	J.Doe@neuclone.com	50%

Frequently Asked Questions

What is NeuClone's official website and social media links?

NeuClone's official website is neuclone.com and has social profiles on LinkedIn.

What is NeuClone's NAICS code?

NeuClone's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does NeuClone have currently?

As of December 2025, NeuClone has approximately 11 employees across 2 continents, including OceaniaNorth America. Key team members include Cfo / Legal Counsel / Director: J. M.Chief Development Officer: P. A.Head Of Global Business Development And Alliances: J. O.. Explore NeuClone's employee directory with LeadIQ.

What industry does NeuClone belong to?

NeuClone operates in the Pharmaceutical Manufacturing industry.

What technology does NeuClone use?

NeuClone's tech stack includes RSSCloudflareoEmbedMicrosoft 365ProgressBar.jsModernizrPHPTouchSwipe.

What is NeuClone's email format?

NeuClone's email format typically follows the pattern of F.Last@neuclone.com. Find more NeuClone email formats with LeadIQ.

NeuClone

Q: What is NeuClone's official website and social media links?

NeuClone's official website is neuclone.com. NeuClone has social profiles on LinkedIn.

Q: How many employees does NeuClone have currently?

NeuClone has approximately 11 employees.

Q: What technology does NeuClone use?

NeuClone's tech stack includes Font Awesome, Contact Form 7, ProgressBar.js, jQuery, Apache.

Pharmaceutical ManufacturingNew South Wales, Australia11-50 Employees

NeuClone is a clinical stage biopharmaceutical company exclusively developing and commercialising high quality biosimilar products. Led by a team of industry veterans, we are focused on creating a deep pipeline of high quality biosimilars at the scale and price to meet demand in both new and established markets globally. NeuClone is differentiated by our deep and unmatched pipeline, as well as our Right From the Start® approach where we continually confirm biosimilarity at the earliest stages and throughout development.